Celiac Disease Drugs Market 2017 Global Industry Analysis, Key Vendors, Opportunity & Forecast to 2021

Celiac Disease Drugs Market 2017

Executive Summary
Celiac disease is an autoimmune inflammatory disease of the small intestine, which is triggered by intake of gluten from wheat and other sources through our food. Presently, there is no specific drug approved for celiac disease, and the first line of treatment is completely dominated by a gluten-free diet. There are few anti-inflammatory and immunosuppressant drugs and nutritional supplements that are used as off-label therapy in celiac disease. All these off-label therapies are considered as second-line of treatment.

The analysts forecast the global celiac disease drugs market to grow at a CAGR of 24.22% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global celiac disease drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1522087-global-celiac-disease-drugs-market-2017-2021

 

The report, Global Celiac Disease Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Merck
  • Pfizer

Other prominent vendors

  • ADMA Biologics
  • Amgen
  • Anthera Pharmaceuticals
  • Bayer
  • Biogen
  • BioLineRx
  • Biotest
  • Bristol-Myers Squibb
  • Celgene
  • Celimmune
  • ImmunogenX
  • Immunomedics
  • ImmusanT
  • Innovate Biopharmaceuticals
  • Kedrion Biopharma
  • LFB Group
  • Novartis
  • Shire
  • Takeda Pharmaceutical

Market driver

  • Prevalence of disease
  • For a full, detailed list, view our report

Market challenge

  • Long-term sustainability
  • For a full, detailed list, view our report

Market trend

  • Inorganic growth strategies
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

 

Complete Report Details https://www.wiseguyreports.com/reports/1522087-global-celiac-disease-drugs-market-2017-2021

 

Table of Contents

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: An overview of celiac disease
PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Pipeline landscape
PART 08: Market segmentation by therapy type
• First line of treatment
• Second line of treatment

PART 09: Geographical segmentation
• Celiac disease drugs market in Americas
• Celiac disease drugs market in EMEA
• Celiac disease drugs market in APAC

PART 10: Decision framework
PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Inorganic growth strategies
• Robust pipeline

....Continued

 

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check:

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check:

https://www.wiseguyreports.com/seminars

 

CONTACT US:

Norah Trent

Partner Relations & Marketing Manager

sales@wiseguyreports.com

http://www.WiseGuyReports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s